William Motley - Profile and Investment Details

Find investors who align with your industry, stage, and vision. Unlock William Motley’s full investment profile, including location, investment focus, portfolio companies, and preferences. Sign up today and start building investor relationships that fuel your startup’s growth.

Get connected with all investors today
Investor type
Country
City/Area
Stages

-

Contacts
Emailfir***@***.com Available after registration.
Markets
Past investments
Goldfinch BiopharmaBlueprint MedicinesMagenta TherapeuticsLarimar TherapeuticsConstellation PharmaceuticalsJounce TherapeuticsMotus TherapeuticsPanOpticaWarp Drive BioEditas MedicineEmber TherapeuticsMOMA TherapeuticsRelay TherapeuticsDecibel TherapeuticsCytomX TherapeuticsTopica PharmaceuticalsCibiem, Inc.AlcrestaRhythm MetabolicAgios PharmaceuticalsRheos MedicinesCMT Research FoundationLotus Tissue RepairBluebird BioCorvia MedicalAfferent PharmaceuticalsFoundation MedicineFulcrum TherapeuticsVoyager TherapeuticsSeventh Sense BiosystemsPalvella TherapeuticsMaze TherapeuticsNeon TherapeuticsTARIS BiomedicalNinePoint MedicalAsher BioMyoKardiaThrive Earlier DetectionCelsius TherapeuticsIgenicaCedilla TherapeuticsCasma TherapeuticsFlare TherapeuticsEdimer PharmaceuticalsPliant TherapeuticsSesen Bio, Inc.Element ScienceInsitroSoffio MedicalRevolution MedicinesFaze MedicinesAmbys MedicinesGlobal Blood TherapeuticsKala PharmaceuticalsRhythm PharmaceuticalsNurix TherapeuticsTango TherapeuticsSAGE TherapeuticsAllena Pharmaceuticals
Investor Profile

William Motley is a Venture Capital based in Boston, Massachusetts, United States with a diverse investment portfolio that includes companies such as Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics, Constellation Pharmaceuticals, Jounce Therapeutics, Motus Therapeutics, PanOptica, Warp Drive Bio, Editas Medicine, Ember Therapeutics, MOMA Therapeutics, Relay Therapeutics, Decibel Therapeutics, CytomX Therapeutics, Topica Pharmaceuticals, Cibiem, Inc., Alcresta, Rhythm Metabolic, Agios Pharmaceuticals, Rheos Medicines, CMT Research Foundation, Lotus Tissue Repair, Bluebird Bio, Corvia Medical, Afferent Pharmaceuticals, Foundation Medicine, Fulcrum Therapeutics, Voyager Therapeutics, Seventh Sense Biosystems, Palvella Therapeutics, Maze Therapeutics, Neon Therapeutics, TARIS Biomedical, NinePoint Medical, Asher Bio, MyoKardia, Thrive Earlier DetectionCelsius Therapeutics, Igenica, Cedilla Therapeutics, Casma Therapeutics, Flare Therapeutics, Edimer Pharmaceuticals, Pliant Therapeutics, Sesen Bio, Inc., Element Science, Insitro, Soffio Medical, Revolution Medicines, Faze Medicines, Ambys Medicines, Global Blood Therapeutics, Kala Pharmaceuticals, Rhythm Pharmaceuticals, Nurix Therapeutics, Tango Therapeutics, SAGE Therapeutics, Allena Pharmaceuticals, . Over time, William Motley has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether William Motley is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Drug Discovery, Wellness, Women Founded, Life Science, Engineering, Biotechnology, Drug Development, Precision Medicine, Neuroscience, Clinical Trials, Research, Health Diagnostics, Regulatory Compliance, Medical, B2B, Therapeutics, Pharmaceuticals may find it worthwhile to explore potential connections with William Motley, as their portfolio suggests a familiarity and interest in this area.

Understanding William Motley’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.

Finally raise your round with Angel Match

Angel Match is the easiest way to research investors for your startup so you can spend less time Googling and more time raising.

Find the perfect investors today